Mani's job is to be very nice, very professional, soothe investors' nerves, and put on best face for the company. She has done all these things well the numerous times I've spoken to her. However and I guess this is the issue for all little biotechs, where is the accountability for the CEO when they miss every fawking goal stated for a 12 month period???? Oh that's right, give them another 1M shares, pat them on the head, and say good job. Really. In the "real" world jobs, who would get away with such a performance and then be handsomely rewarded? He can say well that is part of the agreement. BUT he could make a gesture of good faith and return them in some fashion. And you can say many of the things are out of their control......but not the over promise/under deliver fact! How much backbone does it take to just step up and give a periodic update and explain why things are delayed to keep investors informed. Perhaps also called professionalism???
I believe many people missed in the last PR (12/6) when Ali created an out for when PII would start leaving it open ended.. And then again I may be mistaken or I'm tramping on pumpers' feet. Sorry. And I quote,
"We are pleased to report promising clinical activity of CUDC-907 in patients with DLBCL, particularly those with tumors that harbor MYC alterations," said Ali Fattaey, Ph.D., Curis' President and Chief Executive Officer. "These clinical results are consistent with our preclinical observations where CUDC-907 has a rapid and dramatic effect on MYC protein levels and provides significant anti-tumor activity in in vivo models. We are thankful to our patients for their participation in the Phase 1 clinical trial and, based on these data, we expect the start of a Phase 2 trial that will exclusively enroll patients with relapsed/ refractory DLBCL known to have MYC alterations based on pre-specified selection criteria." No date stated for start up and this is the last we heard from them going on 2 months. Now I would expect to hear the official announcement the beginning of the week for the BIO prez, which we have a great time to present...when everyone is eating supper.
Sales for the year +15% ~$167M. ASSUMING I did this right (conversion, interpretation of the charts), not sure how this works with the competition that came on market to possibly reduce our commission vs. our commission going up a % point with the sales exceeding the necessary level to be awarded that. Also we have currently 3 sites open for each of the trials pertaining to both myelofibrosis and idiopathic pulmonary fibrosis. At this time there are a possible 23 locations for MF and 15 locations for IPF.
Right Tar. That's what old school means. Jeesh! But back to the topic. Yes I do see it there. Fascinating that the "formal" list I saw posted at Twitter omitted them.
Regret I didn't get in sooner but where this is going 2-4 years down the road and where our economy is going....no problem. In now and in 5 years easy 3-500% upside.
Sentiment: Strong Buy
Ali rocks!!!!! Told ya to back up the truck!!!!!! Let's see buy at 1.62 + .38 at the moment.......let me get the abacus out. Woooooo!!!!!
Sentiment: Strong Buy
No no no and what is going on in the world has no effect on individual stocks. Every stock has its own special vacuum. lolol
Sentiment: Strong Buy
Very sorry to see you go. Good luck in your future investments. Doesn't leave many of us LT folks here-that post on occasion anyway. For the most part I try like heck to minimize my thinking of this but difficult considering it is my largest investment. Re: the very imminent phrase, total sarcasm on my part but true relative to the inept CEO's comment of being imminent weeks ago. Perhaps he is a good lab rat only....hopefully??? Imagine someone in the real world making promises like that for the next 12 months and not hitting one of them. But gosh he sure is making real money and getting real bonuses. And people thought Dan was bad........
I don't think anyone really wants to look closely at Ali's scorecard since coming on board.....unfortunately. I have to wonder how long the board allows him to continue and NOT increase the value of the company.....to date anyway. Here's to hoping he begins moving the company forward....PII, IND's, etc.